LIXTE BIOTECHNOLOGY HOLDINGS, INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lixte Biotechnology Holdings, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Lixte Biotechnology Holdings, Inc. Return On Assets for the quarter ending September 30, 2024 was -131 %, a 4.56% decline year-over-year.
  • Lixte Biotechnology Holdings, Inc. annual Return On Assets for 2023 was -120 %, a 16.5% decline from 2022.
  • Lixte Biotechnology Holdings, Inc. annual Return On Assets for 2022 was -103 %, a 1.62% decline from 2021.
  • Lixte Biotechnology Holdings, Inc. annual Return On Assets for 2021 was -101 %, a 16.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -120 -16.9 -16.5% Jan 1, 2023 Dec 31, 2023
2022 -103 -1.64 -1.62% Jan 1, 2022 Dec 31, 2022
2021 -101 +20.1 +16.5% Jan 1, 2021 Dec 31, 2021
2020 -121 -48.1 -65.5% Jan 1, 2020 Dec 31, 2020
2019 -73.3 +63.9 +46.6% Jan 1, 2019 Dec 31, 2019
2018 -137 -16.7 -13.9% Jan 1, 2018 Dec 31, 2018
2017 -120 +94.6 +44% Jan 1, 2017 Dec 31, 2017
2016 -215 +21 +8.91% Jan 1, 2016 Dec 31, 2016
2015 -236 +130 +35.4% Jan 1, 2015 Dec 31, 2015
2014 -366 -230 -170% Jan 1, 2014 Dec 31, 2014
2013 -136 +96.5 +41.6% Jan 1, 2013 Dec 31, 2013
2012 -232 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.